SCHEMBL24289082

SCHEMBL24289082

C=C(C)CCCC1CCCC(=C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6338008 0.76 CYP1A2 (0.52) —
SCHEMBL24619815 0.75 KDM4E (0.39) —
SCHEMBL11274166 0.71 SIGMAR1 (0.47) —
SCHEMBL11262734 0.71 CYP1A2 (0.50) —
SCHEMBL23280791 0.70 — —
SCHEMBL13413769 0.70 — —
SCHEMBL11274111 0.69 SIGMAR1 (0.50) —
SCHEMBL11255472 0.66 KDM5A (0.41) —
SCHEMBL22883611 0.66 — —
SCHEMBL20343055 0.66 LMNA (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022073469-A1 COMPOUNDS AND METHODS OF TREATING CANCERS CULLGEN (SHANGHAI) , INC. (CN) 2022-04-14 — — WO disclosed
Send feedback